| Workgroup of Stereotactic Body Radiation Therapy.Shanghai Medical Association Radiation Oncologists consensus on stereotactic body radiation therapy for prostate cancer[J].Chinese Journal of Radiological Medicine and Protection,2025,45(4):261-274 |
| Shanghai Medical Association Radiation Oncologists consensus on stereotactic body radiation therapy for prostate cancer |
| Received:July 25, 2024 |
| DOI：10.3760/cma.j.cn112271-20240725-00277 |
| KeyWords:Prostate cancer Stereotactic body radiation therapy Consensus |
| FundProject:海军军医大学第一附属医院"长风"人才培养计划;长海医院"固海"计划(GH145-33) |
|
| Hits: 253 |
| Download times: 86 |
| Abstract:: |
| Compared to other solid tumors, prostate cancer exhibits a continuously rising incidence rate and mortality in China. For localized prostate cancer, radiation therapy is the second only to surgery as a significant treatment means. Stereotactic body radiation therapy (SBRT) has emerged as an effective, convenient, and safe therapy by leveraging advanced physical planning, precise image guidance, and ultrahypofractionated exposure. This approach has partly superseded conventional fractionated radiotherapy regimens. Although several prospective and retrospective clinical studies on SBRT for prostate cancer have been published, they show incomplete evidence integrity and inconsistent treatment protocols. Under the auspices of the Branch Association of Radiation Oncology of Shanghai Medical Association, the Group of Stereotactic Body Radiation Therapy under this branch association formulated the "Shanghai Medical Association Radiation Oncologists consensus on stereotactic body radiation therapy for prostate cancer" based on available evidence-based medical data and multi-institutional clinical experience. This consensus aims to standardize the application of SBRT in prostate cancer patients, providing practical guidance for radiation oncologists and foundational standards for future multi-institutional collaboration, data sharing, and analysis. |
| HTML View Full Text View/Add Comment Download reader |
| Close |
|
|
|
